COOPERATION. Recently, an important step was taken on the Sahlgrenska Cancer Center’s path towards being accredited as a Comprehensive Cancer Center. The organization that decides on the accreditation, OECI, made a physical site visit on 23 February, where the auditors stated that SCC had come a long way. The establishment of the Sahlgrenska Cancer Center (SCC) at Sahlgrenska University Hospital has been ongoing since 2020. The SCC strengthens the collaboration…
Eight researchers at Sahlgrenska Academy receive funding from the Lundberg Foundation
GRANTS. Of the SEK 37 million that has just been awarded by the IngaBritt and Arne Lundberg Research Foundation, most goes to researchers from the University of Gothenburg. Professor Eva Forssell-Aronsson has been given the biggest grant. She can now buy a combined magnetic resonance scanner and positron camera for conducting research on radioactive pharmaceuticals to treat metastatic cancer. Eva Forssell-Aronsson, a medical physicist and professor of medical radiation physics,…
Increased survival with eye melanoma in clinical trial
NEW STUDY. Once it has spread (metastasized), uveal (intraocular or eye) melanoma — an unusual form of cancer — has a very high mortality rate. In a study published in Nature Communications, researchers and doctors at the University of Gothenburg and Sahlgrenska University Hospital show that, in a small group of patients with metastatic uveal melanoma, a new combination treatment can bring about tumor shrinkage and prolonged survival. Uveal melanoma,…
Basic research saves lives in children with high-risk neuroblastoma
NEW STUDY. Thanks to many years of basic research into the rare cancer neuroblastoma, some very seriously ill children can now be returned to health. The treatment is simple, has significantly fewer side effects, and has a surprisingly fast effect. A major European collaboration, which includes researchers at the University of Gothenburg and Karolinska Institutet, has now published its results in the Journal of Clinical Oncology. It will have a…
Long sick leave after low-grade brain tumor
STUDY. One year after the diagnosis of low-grade malignant brain tumor, a University of Gothenburg study shows, just under three people in ten were in full-time employment. Another year later, the proportion remained below half. For this young patient group, returning to work is a key health factor. Every year, some 100 people in Sweden are diagnosed with low-grade brain tumor (also known as low-grade glioma). This type of tumor…